Allspring Global Investments Holdings, LLC Nektar Therapeutics Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
BUY
$2.03 - $4.28 $114,254 - $240,891
56,283 Added 42.45%
188,869 $0
Q3 2022

Oct 26, 2022
SELL
$3.04 - $5.14 $28,040 - $47,411
-9,224 Reduced 6.5%
132,586 $424,000
Q2 2022

Jul 25, 2022
BUY
$3.17 - $6.17 $34,232 - $66,629
10,799 Added 8.24%
141,810 $538,000
Q1 2022

May 02, 2022
BUY
$4.16 - $13.72 $334,780 - $1.1 Million
80,476 Added 159.25%
131,011 $706,000
Q4 2021

Jan 28, 2022
BUY
$10.83 - $18.41 $547,294 - $930,349
50,535 New
50,535 $682,000

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email